(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione, 95.0%, 5g

4-(4-Methylbenzoyl)-1H-pyrrole-2-carboxylic acid, 95%, 100mg

ETHYL 4-CYCLOPROPYL-1-(3-METHOXYPHENYL)-1H-1,2,3-TRIAZOLE-5-CARBOXYLATE, 95.0%, 100mg

4'-Fluoro-3'-methyl-2,2,2-trifluoroacetophenone, 97.0%, 1g

Screw vials conical, 2 ml, 1000 Piece(s)

1-[3-(Trifluoromethyl)pyrid-2-yl]-1,4-diazepane, 95.0%, 10g

METHYL 6-BROMO-1-(SEC-BUTYL)-3-FORMYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 1g

2-Chloro-6-ethoxyquinoline-3-carbaldehyde, 98%, 250mg

2-(2-Propoxyphenoxy)acetic acid, 95%, 100mg

D-Raffinose pentahydrate, 98.0%, 5g

1-Benzyl-3,3-difluoropiperidin-4-one, 95.0%, 5g

ANS-NH4 (=Ammonium 8-Anilino-1-naphthalenesulfonate) [Hydrophobic fluorescent probe]>95.0%(HPLC)(T)1g

Tetrahydrofuran-3-carbaldehyde 50% in water, 95.0%, 100g